ADJUVANS
ADJUVANS has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.37M and a net result of €101k. Equity remains stable across the filed fiscal years (±0.8% per year). Its solvency ranks better than 84% of 9197 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
| Equity | €1.37M |
| Net result | €101k |
| Better than sector | 84% |
| Active | 21 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 84.6% | 54.7% | |
| Net result | €101k | €17k | |
| Equity | €1.37M | €67k | |
| Gross operating margin | €112k | €40k | |
| Total assets | €1.62M | €142k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €107k | €125k | €115k | €115k | €193k |
| Net profit | €101k | €65k | €79k | €77k | €129k |
| Cash flow | €130k | €108k | €99k | €92k | €144k |
| Staff costs | - | - | - | - | - |
| Income taxes | €43k | €26k | €31k | €31k | €55k |
| Dividends | - | €0 | €139k | €112k | €0 |
| Total assets | €1.62M | €1.45M | €1.43M | €1.43M | €1.38M |
| Equity | €1.37M | €1.27M | €1.20M | €1.26M | €1.30M |
| Debt | €249k | €178k | €223k | €169k | €77k |
| of which ≤ 1y | €245k | €175k | €220k | €167k | €75k |
| of which > 1y | €2k | €2k | €2k | €1k | €1k |
| Working capital | €925k | €796k | €825k | €930k | €951k |
| Employees (FTE) | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 4.78 | 5.54 | 4.74 | 6.57 | 13.74 |
| Quick ratio | 4.78 | 5.54 | 4.74 | 6.57 | 13.74 |
| Working capital ratio | 57.1% | 55.0% | 57.8% | 64.8% | 69.0% |
| Solvency | 84.6% | 87.7% | 84.4% | 88.2% | 94.4% |
| Debt / equity | 0.18 | 0.14 | 0.19 | 0.13 | 0.06 |
| Long-term debt ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest coverage | 14.32 | 20.52 | 521.00 | 103.93 | 118.76 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 6.2% | 4.5% | 5.5% | 5.4% | 9.4% |
| ROE | 7.3% | 5.1% | 6.5% | 6.1% | 10.0% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Full annual accounts (24 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €1.62M | €1.45M | €1.43M | €1.43M | €1.38M |
| Fixed assets | 21/28 | €450k | €476k | €382k | €337k | €352k |
| Tangible fixed assets | 22/27 | €450k | €476k | €382k | €337k | €352k |
| Current assets | 29/58 | €1.17M | €972k | €1.05M | €1.10M | €1.03M |
| Amounts receivable within one year | 40/41 | €154k | €198k | €100k | €133k | €183k |
| Investments | 50/53 | €671k | €688k | €760k | €564k | €537k |
| Cash & bank | 54/58 | €335k | €78k | €172k | €391k | €296k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.62M | €1.45M | €1.43M | €1.43M | €1.38M |
| Equity | 10/15 | €1.37M | €1.27M | €1.20M | €1.26M | €1.30M |
| Contributions / capital | 10/11 | €19k | €19k | €19k | €19k | €19k |
| Reserves | 13 | €1.27M | €1.17M | €1.11M | €1.17M | €1.20M |
| Accumulated profits (losses) | 14 | €79k | €79k | €79k | €79k | €79k |
| Amounts payable | 17/49 | €249k | €178k | €223k | €169k | €77k |
| Amounts payable after one year | 17 | €2k | €2k | €2k | €1k | €1k |
| Amounts payable within one year | 42/48 | €245k | €175k | €220k | €167k | €75k |
| Trade debts payable within one year | 44 | €125k | €30k | €14k | €21k | €18k |
| Income statement | ||||||
| Gross operating margin | 9900 | €112k | €131k | €120k | €118k | €197k |
| Operating result | 9901 | €77k | €82k | €94k | €100k | €179k |
| Financial income | 75 | €74k | €14k | €16k | €9k | €8k |
| Financial charges | 65 | €7k | €6k | €220 | €1k | €2k |
| Result before taxes | 9903 | €144k | €90k | €110k | €108k | €185k |
| Income taxes | 67/77 | €43k | €26k | €31k | €31k | €55k |
| Net result for the period | 9904 | €101k | €65k | €79k | €77k | €129k |
| Result to be appropriated | 9905 | €101k | €65k | €79k | €77k | €129k |
| NACE primary | Engineering and related technical consultancy, excluding land surveyors(71121) |
| Legal form | Private limited company(610) |
| Incorporation | 29-10-2004 |
| Status | Active |
| Postal code | 2800 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12402B0166/00R006 | Flanders | 1,236 m² | 1 · 156 m² | 11.3 m · 2 fl. |
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
| Legal nameNL | ADJUVANS |